Skip to main content

Advertisement

Log in

A pilot randomized study on use of oral acetazolamide in patients with refractory dysuria

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Assessment of daily oral acetazolamide in treatment of refractory dysuria.

Methods

Forty-one patients were randomly allocated to either be treated with acetazolamide (250 mg twice daily) or to receive placebo. The irritative voiding symptoms and urinary pH were recorded before and after treatment. The quality of life indices including the impact of voiding symptoms on daily and social activities, mood disturbance and sleep disorders were also measured by a questionnaire.

Results

Urinary pH was increased in the group taking acetazolamide (P < 0.001). They also reported alleviation of dysuria (P < 0.001), frequency (P = 0.039) and urgency (P = 0.016). However, nocturia was not improved in the study group. No change was observed in the aforementioned parameters in the placebo group. Daily personal life, social activities and the quality of sleep were improved by 52, 38 and 33%, respectively.

Conclusion

Oral acetazolamide can reduce the irritative voiding symptoms and improve the quality of life which is concomitant with an increase in urinary pH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Ditchburn RK, Ditchburn JS (1990) A study of microscopical and chemical tests for the rapid diagnosis of urinary tract infections in general practice. Br J Gen Pract 40(339):406–408

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Verest L, Van Esch W, Van Ree J, Stobberingh E (2000) Management of acute uncomplicated urinary tract infections in general practice in the south of The Netherlands. Br J Gen Pract 50(453):309–310

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Stamm WE, Wagner KF, Amsel R, Alexander ER, Turck M, Counts GW et al (1980) Causes of the acute urethral syndrome in women. N Engl J Med 303(8):409–415

    Article  CAS  PubMed  Google Scholar 

  4. Henry R, Patterson L, Avery N, Tanzola R, Tod D, Hunter D et al (2001) Absorption of alkalized intravesical lidocaine in normal and inflamed bladders: a simple method for improving bladder anesthesia. J Urol 165(6):1900–1903

    Article  CAS  PubMed  Google Scholar 

  5. Hohlbrugger G, Lentsch P (1984) Intravesical ions, osmolality and pH influence the volume pressure response in the normal rat bladder, and this is more pronounced after DMSO exposure. Eur Urol 11(2):127–130

    Google Scholar 

  6. Nguan C, Franciosi LG, Butterfield NN, Macleod BA, Jens M, Fenster HN (2005) A prospective, double-blind, randomized cross-over study evaluating changes in urinary pH for relieving the symptoms of interstitial cystitis. BJU Int 95(1):91–94

    Article  PubMed  Google Scholar 

  7. Spooner J (1984) Alkalinisation in the management of cystitis. J Int Med Res 12(1):30–34

    Article  CAS  PubMed  Google Scholar 

  8. Parsons CL (2007) The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology 69(4):S9–S16

    Article  Google Scholar 

  9. O’Kane DB, Dave SK, Gore N, Patel F, Hoffmann T, Del Mar CB (2013) Urinary alkalisation for uncomplicated urinary tract infection. Cochrane Libr. doi:10.1002/14651858.CD010745

    Google Scholar 

  10. Brumfitt W, Hamilton-Miller J, Cooper J, Raeburn A (1990) Relationship of urinary pH to symptoms of’cystitis’. Postgrad Med J 66(779):727–729

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Munday P, Savage S (1990) Cymalon in the management of urinary tract symptoms. Genitourin Med 66(6):461

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Gargan R, Hamilton-Miller J, Brumfitt W (1993) Effect of alkalinisation and increased fluid intake on bacterial phagocytosis and killing in urine. Eur J Clin Microbiol Infect Dis 12(7):534–539

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Funding was received by Aja University of Medical Sciences.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Morteza Hamidi.

Ethics declarations

Conflict of interest

Authors declare no conflict of interest.

Ethical approval

All procedures performed in this study were in accordance with the ethical standards of our institutional review board and with the 1964 Helsinki declaration and its later amendments.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hamidi, M., Aghamir, S.M.K., Salavati, A. et al. A pilot randomized study on use of oral acetazolamide in patients with refractory dysuria. Int Urol Nephrol 49, 927–930 (2017). https://doi.org/10.1007/s11255-017-1566-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-017-1566-2

Keywords

Navigation